Lupin Appoints Claus Jepsen as President, Global Specialty Business
By Rediff Money Desk, New Delhi Oct 21, 2024 18:03
Lupin, a leading drug firm, has appointed Claus Jepsen as President of its Global Specialty business. Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
New Delhi, Oct 21 (PTI) Drug firm Lupin on Monday said it has appointed Claus Jepsen as President, Global Specialty business.
Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.
Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- G G Engineering
- 2.13 (+ 12.11)
- 70001344
- Vodafone Idea L
- 7.67 ( -5.66)
- 68482952
- Srestha Finvest
- 0.66 ( -4.35)
- 32525731
- GTL Infrastructure
- 1.98 ( -4.81)
- 26692659
- AvanceTechnologies
- 0.82 (+ 2.50)
- 23608944
MORE NEWS
Cryptocurrency Risks to Financial Stability:...
RBI Governor Shantikanta Das warns of significant risks to financial stability posed by...
Soft Landing of Global Economy Possible:...
India's Finance Minister Nirmala Sitharaman says a soft landing of the global economy...
Coal India Q2 Profit Drops 22% to Rs 6,275 Cr
Coal India Ltd (CIL) reported a 22% drop in consolidated profit for the quarter ended...